Sichuan Dowell Science and Technology Inc.

SZSE:300535 Stock Report

Market Cap: CN¥1.6b

Sichuan Dowell Science and Technology Past Earnings Performance

Past criteria checks 0/6

Sichuan Dowell Science and Technology's earnings have been declining at an average annual rate of -29.6%, while the Chemicals industry saw earnings declining at 0.8% annually. Revenues have been growing at an average rate of 11.5% per year.

Key information

-29.58%

Earnings growth rate

-30.08%

EPS growth rate

Chemicals Industry Growth12.10%
Revenue growth rate11.51%
Return on equity-3.53%
Net Margin-1.85%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) Shares May Have Run Too Fast Too Soon

Dec 19
Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) Shares May Have Run Too Fast Too Soon

Returns On Capital At Sichuan Dowell Science and Technology (SZSE:300535) Have Hit The Brakes

Jun 06
Returns On Capital At Sichuan Dowell Science and Technology (SZSE:300535) Have Hit The Brakes

We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve

May 01
We Think Sichuan Dowell Science and Technology's (SZSE:300535) Profit Is Only A Baseline For What They Can Achieve

What Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) 36% Share Price Gain Is Not Telling You

Mar 08
What Sichuan Dowell Science and Technology Inc.'s (SZSE:300535) 36% Share Price Gain Is Not Telling You

Returns On Capital Signal Tricky Times Ahead For Sichuan Dowell Science and Technology (SZSE:300535)

Feb 26
Returns On Capital Signal Tricky Times Ahead For Sichuan Dowell Science and Technology (SZSE:300535)

Revenue & Expenses Breakdown

How Sichuan Dowell Science and Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300535 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25748-1413654
31 Dec 24753-1113350
30 Sep 247472514448
30 Jun 247744413445
31 Mar 247673313347
31 Dec 237252812542
30 Sep 236472111237
30 Jun 23569611131
31 Mar 23520-310429
01 Jan 23510-210330
30 Sep 225301810539
30 Jun 225804010740
31 Mar 226196111040
01 Jan 226306611342
30 Sep 21655809344
30 Jun 21625869144
31 Mar 21542748542
31 Dec 20470578537
30 Sep 204224510636
30 Jun 203752410738
31 Mar 203722410739
31 Dec 193963910539
30 Sep 193543510931
30 Jun 193554010327
31 Mar 193614210625
31 Dec 183564110224
30 Sep 18364459025
30 Jun 18349468032
31 Mar 18334468225
31 Dec 17333528320
30 Sep 17335618114
30 Jun 1731759920
31 Mar 1731261850
31 Dec 1629958830
30 Sep 1628857780
30 Jun 1628254760
31 Mar 1627049730
31 Dec 1527548720
31 Dec 1427040740

Quality Earnings: 300535 is currently unprofitable.

Growing Profit Margin: 300535 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300535 is unprofitable, and losses have increased over the past 5 years at a rate of 29.6% per year.

Accelerating Growth: Unable to compare 300535's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300535 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (3.3%).


Return on Equity

High ROE: 300535 has a negative Return on Equity (-3.53%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/25 16:15
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sichuan Dowell Science and Technology Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.